Brighten Optix Corp Ordinary Shares 6747
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 21.55
- Price/Sales
- 5.85
- Dividend Yield (Trailing)
- 5.05%
- Dividend Yield (Forward)
- —
- Total Yield
- 5.05%
Company Profile
Brighten Optix Corp is a Taiwan-based company engaged in the manufacturing of contact lenses. The product offerings of the company include Corneal plastic film, Hard contact lenses, Customized soft contact lenses, Hard potion, and Other ancillary products.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- http://www.brightenoptix.com.tw
Comparables
Valuation
|
Metric
|
6747
|
6782
|
3218
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.55 | 50.24 | 21.06 |
Price/Book Value | 3.42 | 5.26 | 6.81 |
Price/Sales | 5.85 | 6.51 | 5.31 |
Price/Cash Flow | 19.49 | 26.11 | 13.88 |
Price/Earnings
6747
6782
3218
Financial Strength
|
Metric
|
6747
|
6782
|
3218
|
|---|---|---|---|
Quick Ratio | 3.95 | 1.27 | 2.18 |
Current Ratio | 4.66 | 2.02 | 2.52 |
Interest Coverage | 284.68 | 9.63 | 83.07 |
Quick Ratio
6747
6782
3218
Profitability
|
Metric
|
6747
|
6782
|
3218
|
|---|---|---|---|
Return on Assets (Normalized) | 13.91% | 6.22% | 21.94% |
Return on Equity (Normalized) | 16.73% | 10.56% | 38.23% |
Return on Invested Capital (Normalized) | 15.33% | 7.92% | 28.25% |
Return on Assets
6747
6782
3218
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Tjbwcrtwh | Jwymyy | $182.7 Bil | |
SYK
| Stryker Corp | Nhhzmhcxn | Hyzl | $124.6 Bil | |
MDT
| Medtronic PLC | Vctbpry | Slpcnd | $105.2 Bil | |
BSX
| Boston Scientific Corp | Zpvkdxdr | Cyhyr | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Grtbkqyjjd | Wzcrj | $52.0 Bil | |
DXCM
| DexCom Inc | Fjngrpnnp | Dsbh | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Dxprcstfd | Mnkqv | $24.5 Bil | |
ALGN
| Align Technology Inc | Gxhqwsty | Hfmrd | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Trsqxjcv | Ndhhgs | $18.3 Bil | |
PODD
| Insulet Corp | Lgyfnjdnvf | Pkclff | $11.6 Bil |